These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 31456586)
21. Patients with Polyvascular Disease: A Very High-risk Group. Manolis AA; Manolis TA; Manolis AS Curr Vasc Pharmacol; 2022; 20(6):475-490. PubMed ID: 36098413 [TBL] [Abstract][Full Text] [Related]
22. Lack of Correlation of Carotid Intima-Media Index and Peripheral Artery Disease. Laguna P; Robles NR; Lopez Gomez J; Barroso S; Collado G High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):379-383. PubMed ID: 30251108 [TBL] [Abstract][Full Text] [Related]
23. [Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk]. Rada C; Oummou S; Merzouk F; Amarir B; Boussabnia G; Bougrini H; Benzaroual D; Elkarimi S; Elhattaoui M J Mal Vasc; 2016 Dec; 41(6):353-357. PubMed ID: 27865565 [TBL] [Abstract][Full Text] [Related]
24. Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease. Adam L; Strickler E; Borozadi MK; Bein S; Bano A; Muka T; Drexel H; Dopheide JF J Clin Med; 2023 May; 12(10):. PubMed ID: 37240515 [No Abstract] [Full Text] [Related]
25. Prevalence of multifocal atherosclerosis and comorbidity on symptomatic Cypriot inpatients. Bekos C; Pieri L; Angelides N; Moros I Int Angiol; 2008 Oct; 27(5):419-25. PubMed ID: 18974706 [TBL] [Abstract][Full Text] [Related]
26. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death. Zhang Q; Wang A; Zhang S; Li N; Chen S; Zhang Y; Zhou Y; Wu S; Zhao X Atherosclerosis; 2017 Jul; 262():1-7. PubMed ID: 28463782 [TBL] [Abstract][Full Text] [Related]
27. Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft. Song P; Seok JM; Kim WS; Lee YT; Kim DK; Kim GM Atherosclerosis; 2011 Nov; 219(1):285-90. PubMed ID: 21708382 [TBL] [Abstract][Full Text] [Related]
28. Progression of polyvascular disease--is there any rule? Despotovic N; Erceg P; Brajovic M; Sekularac N; Milosevic D; Davidovic M Adv Gerontol; 2008; 21(3):420-3. PubMed ID: 19432176 [TBL] [Abstract][Full Text] [Related]
29. Relationship between symptomatic lower limb peripheral artery disease and calcified carotid artery plaque detected on panoramic images of neurologically asymptomatic males. Tran HA; O'Connell JB; Lee UK; Polanco JC; Chang TI; Friedlander AH Dentomaxillofac Radiol; 2019 Jul; 48(5):20180432. PubMed ID: 30875245 [TBL] [Abstract][Full Text] [Related]
30. The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients. van der Meer MG; Cramer MJ; van der Graaf Y; Appelman Y; Doevendans PA; Nathoe HM; Eur J Clin Invest; 2014; 44(3):231-9. PubMed ID: 24372467 [TBL] [Abstract][Full Text] [Related]
31. Associations Between Polyvascular Disease and Stroke Recurrence in Patients With Lacunar Stroke. Ma L; Wang A; Zhang Y; Wang Y; Wang Y; Meng X Front Neurol; 2021; 12():706991. PubMed ID: 34566851 [No Abstract] [Full Text] [Related]
32. How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology. Poredos P; Blinc A; Novo S; Antignani PL Int Angiol; 2021 Feb; 40(1):29-41. PubMed ID: 32892614 [TBL] [Abstract][Full Text] [Related]
33. The peripheral atherosclerotic profile in patients with type 1 diabetes warrants a thorough vascular assessment of asymptomatic patients. Nattero-Chávez L; Redondo López S; Alonso Díaz S; Garnica Ureña M; Fernández-Durán E; Escobar-Morreale HF; Luque-Ramírez M Diabetes Metab Res Rev; 2019 Feb; 35(2):e3088. PubMed ID: 30338903 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. Ness J; Aronow WS; Newkirk E; McDanel D J Gerontol A Biol Sci Med Sci; 2005 Feb; 60(2):255-7. PubMed ID: 15814871 [TBL] [Abstract][Full Text] [Related]
35. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. van Kuijk JP; Flu WJ; Welten GM; Hoeks SE; Chonchol M; Vidakovic R; Verhagen HJ; Bax JJ; Poldermans D Eur Heart J; 2010 Apr; 31(8):992-9. PubMed ID: 20037181 [TBL] [Abstract][Full Text] [Related]
36. Lessons from the REACH Registry in Europe. Valentijn TM; Stolker RJ Curr Vasc Pharmacol; 2012 Nov; 10(6):725-7. PubMed ID: 23259566 [TBL] [Abstract][Full Text] [Related]
37. [Early detection of asymptomatic carotid disease in patients with obliterative arteriosclerosis of the lower extremities]. Rancić Z; Radak D; Stojanović D Srp Arh Celok Lek; 2002; 130(7-8):258-64. PubMed ID: 12585003 [TBL] [Abstract][Full Text] [Related]
38. Carotid Artery Reactivity Predicts Events in Peripheral Arterial Disease Patients. van Mil ACCM; Pouwels S; Wilbrink J; Warlé MC; Thijssen DHJ Ann Surg; 2019 Apr; 269(4):767-773. PubMed ID: 29064890 [TBL] [Abstract][Full Text] [Related]